FrancophonIA/ELRC3.0 huggingface dataset:
English: Bleeding is the most common reaction reported both in clinical studies as well as in post-marketing experience where it was mostly reported during the first month of treatment.
Danish: Blødning er den mest almindeligt indrapporterede bivirkning fra både kliniske studier, såvel som fra postmarketing erfaring, hvor den mestendels blev indrapporteret i løbet af behandlingens første måned.
English: As a precautionary measure, breast-feeding should not be continued during treatment with Clopidogrel BMS.
Danish: Som forholdsregel bør amning ophøre under behandling med Clopidogrel BMS.
English: To date, the impact of CYP2C19 genotype on the pharmacokinetics of the active metabolite of clopidogrel has been evaluated in 227 subjects from 7 reported studies.
Danish: Indtil i dag er effekten af CYP2C19-genotypen på farmakokinetikken af clopidogrels aktive metabolit blevet evalueret hos 227 individer fra 7 rapporterede studier.
English: The association between CYP2C19 genotype and clopidogrel treatment outcome was evaluated in 2 post hoc clinical trial analyses (substudies of CLARITY [n=465] and TRITON-TIMI 38 [n=1,477]) and 5 cohort studies (total n=6,489).
Danish: Sammenhængen mellem CYP2C19-genotype og udfald af clopidogrelbehandlingen blev evalueret i 2 kliniske post-hoc analyser (substudier af CLARITY [n=465] og TRITON-TIMI 38 [n=1.477]) og 5 kohortestudier (total n=6.489).
English: Clopidogrel has been tested in a range of in vitro and in vivo genotoxicity studies, and showed no
Danish: Clopidogrel er testet in vitro og in vivo i en række genotoksicitetsforsøg og udviste ingen genotoksisk
English: The co-primary endpoints were death from any cause and the first occurrence of re-infarction, stroke or death.
Danish: Det primære endepunkt var død uanset årsag og den første forekomst af re-infarkt, slagtilfælde eller død.
English: The patient population included 19.7% women and 29.2% patients ≥ 65 years.
Danish: Patientpopulationen bestod af 19,7 % kvinder og 29,2 % af patienter var over 65 år.
English: This leaflet was last approved in MM/YYYY Detailed information on this medicine is available on the European Medicines Agency (EMEA)
Danish: Denne indlægsseddel blev senest godkendt den MM/ÅÅÅÅ Yderligere information om dette lægemiddel er tilgængelig på Det europæiske Lægemiddelagenturs
English: If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Clopidogrel BMS.
Danish: Hvis De er gravid eller har mistanke om, at De kan være gravid, skal De fortælle det til Deres læge eller apoteket, før De tager Clopidogrel BMS.
English: You should take Clopidogrel BMS for as long as your doctor continues to prescribe it.
Danish: De skal fortsætte med at tage Clopidogrel BMS, så længe Deres læge udskriver det til Dem.
English: Clopidogrel BMS is unlikely to affect your ability to drive or to use machines.
Danish: Det er usandsynligt, at Clopidogrel BMS vil påvirke Deres evne til at køre eller betjene maskiner.
English: 1, rue de la Vierge, Ambarès & Lagrave, F-33565 Carbon Blanc cedex, France
Danish: 1, Rue de la Vierge, Ambarès & Lagrave, F-33565 Carbon Blanc cedex, Frankrig
English: Week 2 (for boxes of 14, 28 and 84 tablets) Week 3 (for boxes of 28 and 84 tablets) Week 4 (for boxes of 28 and 84 tablets)
Danish: Uge 2 Kun for pakninger med 7, 28 og 84 tabletter Uge 3 Kun for pakninger med 28 og 84 tabletter Uge 4 Kun for pakninger med 28 og 84 tabletter
English: There was no evidence of carcinogenic effect when clopidogrel was administered for 78 weeks to mice and 104 weeks to rats when given at doses up to 77 mg/kg per day (representing at least 25 times the exposure seen in humans receiving the clinical dose of 75 mg/day).
Danish: Der var ikke tegn på karcinogen virkning, når clopidogrel blev administreret i 78 uger til mus og 104 uger til rotter og givet i doser op til 77 mg/kg/dag (hvilket udgør mindst 25 gange eksponeringen hos mennesker, der
English: In patients who remained on therapy within five days of bypass graft surgery, the event rate was 9.6% for clopidogrel+ASA, and 6.3% for placebo+ASA.
Danish: Hos patienter, som fortsatte med behandlingen indtil 5 dage før bypassoperationen, var forekomsten 9,6 % for clopidogrel+ASA og 6,3 % for placebo+ASA.
English: Ask your doctor or pharmacist for advice before taking any medicine.
Danish: Spørg om råd hos Deres læge eller på apoteket inden De tager anden medicin.
English: Extensive metabolism: CYP2C19*1/*1
Danish: Stærk metabolisme: CYP2C19*1/*1
English: In patients who were enrolled in the trial on the sole basis of a recent myocardial infarction, clopidogrel was numerically inferior, but not statistically different from ASA (RRR = -4.0%; CI: -22.5 to 11.7 [p=0.639]).
Danish: Hos de patienter, som alene indgik i undersøgelsen på grund af et nyligt myokardieinfarkt, lå clopidogrel numerisk lavere, men ikke statistisk forskelligt fra ASA (RRR = 4,0%, CI: -22,5 til 11,7 [p=0,639]).
English: This benefit was mostly driven by the statistically significant reduction in the incidence of MI [287 (4.6%) in the clopidogrel treated group and 363 (5.8%) in the placebo treated group].
Danish: Fordelen må hovedsageligt tilskrives den statistisk signifikante reduktion i forekomsten af myokardieinfarkt [287 (4,6%) i clopidogrelgruppen og 363 (5,8%) i placebogruppen].
English: Clopidogrel significantly reduced the relative risk of death from any cause by 7% (p = 0.029), and the relative risk of the combination of re-infarction, stroke or death by 9% (p = 0.002), representing an absolute reduction of 0.5% and 0.9%, respectively.
Danish: Clopidogrel reducerede signifikant den relative dødsrisiko uanset årsag med 7 % (p = 0,029) og den relative risiko for kombinationen af re-infarkt, slagtilfæde eller død med 9% (p=0,002), hvilket repræsenterer en absolut reduktion på henholdsvis 0,5% og 0,9%.
English: Rare side effect (affects 1 to 10 patients in 10,000): Vertigo.
Danish: Sjældne bivirkninger (hos 1 til 10 patienter ud af 10000 patienter): Svimmelhed (vertigo)
English: If you become pregnant while taking Clopidogrel BMS, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant.
Danish: Hvis De bliver gravid, mens De tager Clopidogrel BMS, skal De omgående kontakte Deres læge, da det frarådes at tage Clopidogrel BMS hvis De er gravid.
English: Clopidogrel BMS also contains hydrogenated castor oil which may cause stomach upset or diarrhoea.
Danish: Clopidogrel BMS indeholder også hydrogeneret ricinusolie, der kan forårsage mavetilfælde eller diarré
English: In TRITON-TIMI 38 and 3 of the cohort studies (n= 3,516; Collet, Sibbing, Giusti), patients with an impaired metaboliser status (intermediate and poor combined) had a higher rate of cardiovascular events (death, myocardial infarction, and stroke) or stent thrombosis compared to extensive metabolisers.
Danish: I TRITON-TIMI 38 og 3 af kohortestudierne (n=3.516; Collet, Sibbing, Giusti) havde patienter med nedsat metabolismestatus ('moderat nedsat' og 'ringe' metabolisme kombineret) en højere forekomst af kardiovaskulære hændelser (død, myokardieinfarkt og slagtilfælde) eller stent-trombose sammenlignet med patienter med ekstensiv metabolisme.
English: This was consistent across subgroups of patients defined by baseline characteristics, and type of fibrinolytic or
Danish: Dette var ensartet blandt undergrupperne af patienter, defineret ved baseline karakterisktika og typen af fibrinolytika eller heparinbehandling.
English: Due to the risk of bleeding and haematological undesirable effects, blood cell count determination and/or other appropriate testing should be promptly considered whenever clinical symptoms suggestive of bleeding arise during the course of treatment (see section 4.8).
Danish: På grund af risikoen for blødninger og hæmatologiske bivirkninger bør det med det samme overvejes at kontrollere blodstatus og/eller foretage andre passende prøver, hvis der opstår kliniske symptomer, der tyder på blødninger i løbet af behandlingen (se pkt.
English: Data from studies with human liver microsomes indicated that the carboxylic acid metabolite of clopidogrel could inhibit the activity of Cytochrome P450 2C9.
Danish: Data fra studier med humane levermikrosomer viste, at clopidogrels carboxylsyremetabolit kunne hæmme aktiviteten af cytochrom P450 isoenzym 2C9.
English: This 300 mg tablet of clopidogrel is intended for use as a loading dose in patients suffering from
Danish: Denne 300 mg clopidogrel tablet er tiltænkt som stabiliseringsdosis hos patienter med akut
English: In vitro and in vivo, clopidogrel is metabolised according to two main metabolic pathways: one mediated by esterases and leading to hydrolysis into its inactive carboxylic acid derivative (85% of circulating metabolites), and one mediated by multiple cytochromes P450.
Danish: In vitro og in vivo bliver clopidogrel metaboliseret via to primære veje: En esterasemedieret, hvorved det hydrolyseres til dets inaktive carboxylsyrederivat (85 % af de cirkulerende metabolitter), og en medieret af flere cytochrom P450-isoenzymer.
English: In addition to clinical studies experience, adverse reactions have been
Danish: Ud over erfaringerne fra de kliniske studier, er der spontant blevet rapporteret bivirkninger.
English: Clopidogrel BMS contains lactose.
Danish: Clopidogrel BMS indeholder lactose.
English: There may be genetic variants of other CYP450 enzymes with effects on the ability to form the active
Danish: Der kan forekomme genetiske varianter af andre CYP450-enzymer med indflydelse på evnen til at danne den
English: • Paediatric patients The safety and efficacy of clopidogrel in children and adolescents have not yet been established.
Danish: Sikkerhed og virkning af clopidogrel hos børn og unge er endnu ikke fastslået.
English: Heparins were administered in more than 90% of the patients and the relative rate of bleeding between clopidogrel and placebo was not significantly affected by the concomitant heparin therapy.
Danish: Heparin blev givet til over 90% af patienterne, og den relative blødningsforekomst i clopidogrel- og placebogruppen blev ikke signifikant påvirket af den ledsagende heparinbehandling.
English: There is no evidence that other drugs that reduce stomach acid such as H2 blockers or antacids interfere with antiplatelet activity of clopidogrel.
Danish: Der foreligger ikke beviser for, at andre lægemidler, der reducerer mavesyren, såsom H2-blokkere eller antacida, påvirker clopidogrels antitrombotiske aktivitet.
English: There was no excess in major bleeds with clopidogrel + ASA within 7 days after coronary bypass graft surgery in patients who stopped therapy more than five days prior to surgery (4.4% clopidogrel+ASA vs. 5.3% placebo+ASA).
Danish: Der forekom ikke overrepræsentation af større blødninger med clopidogrel + ASA inden for 7 dage efter koronar bypass hos patienter, der indstillede behandlingen mere end 5 dage før indgrebet (4,4 % clopidogrel+ASA versus 5,3 % placebo+ASA).
English: The benefit of the combination of clopidogrel with ASA beyond four weeks has not been studied in this setting (see section 5.1).
Danish: Fordelene ved kombinationsbehandlingen med clopidogrel og ASA udover 4 uger er ikke blevet undersøgt i denne sammensætning (se pkt.
English: Since clopidogrel is metabolised to its active metabolite partly by CYP2C19, use of drugs that inhibit the activity of this enzyme would be expected to result in reduced drug levels of the active metabolite of clopidogrel and a reduction in clinical efficacy.
Danish: Da clopidogrel til dels metaboliseres til dets aktive metabolit af CYP2C19 kan anvendelse af medicin, der hæmmer aktiviteten af dette enzym, forventes at resultere i nedsat niveau af clopidogrels aktive metabolit og nedsat klinisk virkning.
English: In the fifth cohort study (n=2,208; Simon), the increased event rate was observed only in poor metabolisers.
Danish: I det femte kohortestudie (n=2.208; Simon) blev der kun set en øget forekomst af sådanne hændelser hos patienter med ringe metabolisme.
English: To date, diminished antiplatelet responses to clopidogrel have been described for intermediate and poor metabolisers in 21 reported studies involving 4,520 subjects.
Danish: Nedsat trombocytrespons på clopidogrel hos personer med moderat og ringe metabolisme er der til dato blevet beskrevet i 21 rapporterede studier omfattende 4.520 patienter.
English: The use of clopidogrel in CURE was associated with a decrease in the need of thrombolytic therapy (RRR = 43.3%; CI: 24.3%, 57.5%) and GPIIb/IIIa inhibitors (RRR = 18.2%; CI: 6.5%, 28.3%).
Danish: I CURE var anvendelse af clopidogrel forbundet med et aftagende behov for behandling med trombolytika (RRR = 43,3%, CI: 24,3%, 57,5%) og GPIIb/IIIa-hæmmere (RRR = 18,2%, CI: 6,5%, 28,3%).
English: Patients should be told that it might take longer than usual to stop bleeding when they take clopidogrel (alone or in combination with ASA), and that they should report any unusual bleeding (site or duration)
Danish: Patienter i behandling med clopidogrel (alene eller i kombination med ASA) bør informeres om, at det kan tage længere tid end normalt at standse blødninger, samt at de bør kontakte deres læge ved enhver usædvanlig blødning (sted eller varighed).
English: (primary endpoint) were prevented, with relative risk reductions of 22% (CI: 8.6, 33.4), 32% (CI: 12.8, 46.4), 4% (CI: -26.9, 26.7), 6% (CI: -33.5, 34.3) and 14% (CI: -31.6, 44.2), during the 0-1, 1-3, 3-6, 6-9 and 9-12 month study intervals, respectively.
Danish: Nye kardiovaskulære hændelser (primært endpoint) blev forebygget med relative risikoreduktioner på 22 % (CI: 8,6, 33,4) 32 % (CI: 12,8, 46,4), 4 % (CI: -26,9, 26,7), 6 % (CI: -33,5, 34,3) og 14 % (CI: -31,6, 44,2), i løbet af forsøgets intervaller på henholdsvis 0-1, 1-3, 3-6, 6-9 og 9-12 måneder.
English: However, if you are concerned by your bleeding, you should contact your doctor straightaway (see section 4
Danish: Hvis De er bekymret over Deres blødning, skal De omgående kontakte Deres læge (se afsnit 4
English: SPECIAL STORAGE CONDITIONS Store below 30°C (for PVC/PVDC/aluminium blisters) Or No special storage conditions (for all aluminium blisters)
Danish: Opbevares under 30ºC (for PVC/PVDC/aluminium blister) Eller ingen særlige opbevaringsbetingelser (for blisterkort i ren aluminium)
English: This benefit was consistent across all prespecified subgroups including patients' age and gender, infarct location, and type of fibrinolytic or heparin used.
Danish: Denne fordel var konsekvent blandt alle præspecificerede undergrupper, hvor der både blev taget hensyn til patientens alder, køn, hvor infarktet er lokaliseret og den type fibrinolytika eller hepariner der blev anvendt til behandling.
English: In CURE, 823 (6.6%) patients received concomitant GPIIb/IIIa receptor antagonist therapy.
Danish: I CURE blev 823 (6,6%) patienter samtidig behandlet med GPIIb/IIIa-hæmmere.
English: In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both groups (0.6% versus 0.5% in the clopidogrel + ASA and the placebo + ASA groups,
Danish: I COMMIT var den generelle forekomst af non-cerebrale større blødninger eller cerebrale blødninger lav og ensartet i begge grupper (0,6 % versus 0,5 % i hhv. clopidogrel+ASA og placebo+ASA-gruppen).
English: If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Clopidogrel BMS.
Danish: Hvis De mener, at ovenstående gælder for Dem, eller hvis De overhovedet er i tvivl, så rådfør Dem med Deres læge, inden De tager Clopidogrel BMS.
English: The most common side effect (affects 1 to 10 patients in 100) reported with Clopidogrel BMS is bleeding.
Danish: Den mest almindelige bivirkning (hos 1 til 10 patienter ud af 100) der er set med Clopidogrel BMS er
English: • You should tell your doctor or pharmacist if you notice any side effect not listed in section 4 ‘POSSIBLE SIDE EFFECTS' or if you notice that a side effect gets serious.
Danish: • Skal De fortælle det til Deres læge eller på apoteket, hvis De oplever bivirkninger der ikke står i afsnit 4 'BIVIRKNINGER' i denne indlægsseddel, eller hvis De oplever, at den bivirkning bliver alvorlig
English: The safety and efficacy of clopidogrel have been evaluated in 4 double-blind studies involving over 80,000 patients: the CAPRIE study, a comparison of clopidogrel to ASA, and the CURE, CLARITY and COMMIT studies comparing clopidogrel to placebo, both medicinal products given in combination with ASA and other standard therapy.
Danish: Sikkerheden og effekten af clopidrogrel er blevet evalueret i 4 dobbeltblindede forsøg, der omfattede mere end 80.000 patienter, CAPRIE-undersøgelsen, hvor clopidogrel sammenlignes med ASA, og CURE, CLARITY og COMMIT-undersøgelserne, hvor clopidogrel sammenlignes med placebo, og hvor begge lægemidler gives i kombination med ASA eller anden standardterapi.
English: These may be the signs of an allergic reaction.
Danish: Dette kan være tegn på
English: The CAPRIE study included 19,185 patients with atherothrombosis as manifested by recent myocardial infarction (<35 days), recent ischaemic stroke (between 7 days and 6 months) or established peripheral arterial disease (PAD).
Danish: CAPRIE-undersøgelsen omfattede 19.185 patienter med aterotrombose manifesteret ved nyligt myokardieinfarkt (<35 dage), nyligt iskæmisk slagtilfælde (mellem 7 dage og 6 måneder) eller påviste perifere kredsløbsforstyrrelser (PAD).
English: If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Clopidogrel BMS in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever.
Danish: Hvis De har haft alvorlige smerter i brystet (hjertekrampe (ustabil angina pectoris) eller hjerteanfald), kan Deres læge ordinere Clopidogrel BMS i kombination med acetylsalicylsyre, som er et stof, der indgår i mange typer medicin til smertelindring og febersænkning.
English: • You should also tell your doctor immediately if you develop a medical condition that includes fever and bruising under the skin that may appear as red pinpoint dots, with or without unexplained extreme tiredness, confusion, yellowing of the skin or eyes (jaundice) (see section 4
Danish: • Skal De også fortælle det til Deres læge med det samme, hvis De udvikler en medicinsk tilstand, der giver feber og blå mærker under huden, der kan fremstå som små røde prikker, med eller uden uforklarlig ekstrem træthed, forvirring, gulning af huden eller øjnene (gulsot) (se afsnit 4
English: Pharmacogenetics: Based on literature data, patients with genetically reduced CYP2C19 function have lower systemic exposure to the active metabolite of clopidogrel and diminished antiplatelet responses, and generally exhibit higher cardiovascular event rates following myocardial infarction than do patients with normal CYP2C19 function (see section 5.2).
Danish: Farmakogenetik: Baseret på data fra litteraturen har patienter med genetisk nedsat funktion af CYP2C19 lavere systemisk eksponering for clopidogrels aktive metabolit, nedsat antitrombotisk respons og udviser generelt højere frekvens af kardiovaskulære hændelser efter myokardieinfarkt, end patienter med normal
English: The risk of bleeding (life-threatening, major, minor, other) decreased during the course of the trial: 0-1 months (clopidogrel: 9.6%; placebo: 6.6%), 1-3 months (clopidogrel: 4.5%; placebo: 2.3%), 3-6 months (clopidogrel: 3.8%; placebo: 1.6%), 6-9 months (clopidogrel: 3.2%; placebo: 1.5%), 9-12 months (clopidogrel: 1.9%; placebo: 1.0%).
Danish: Risikoen for blødninger (livstruende, større, mindre, andre) faldt under forsøgsforløbet: 0-1 måned (clopidogrel: 9,6 %; placebo: 6,6 %), 1-3 måneder (clopidogrel: 4,5 %; placebo 2,3 %), 3-6 måneder (clopidogrel 3,8 %; placebo: 1,6 %), 6-9 måneder (clopidogrel: 3,2 %; placebo 1,5 %), 9-12 måneder (clopidogrel 1,9 %; placebo 1,0 %).
English: Other side effects reported with Clopidogrel BMS are: Common side effects (affects 1 to 10 patients in 100): Diarrhoea, abdominal pain, indigestion or
Danish: Øvrige bivirkninger rapporteret for Clopidogrel BMS: Almindelige bivirkninger (hos 1 til 10 patienter ud af 100 patienter): Diaré, mavesmerter fordøjelsesbesvær
English: Drugs that inhibit CYP2C19 include omeprazole and esomeprazole, fluvoxamine, fluoxetine, moclobemide, voriconazole, fluconazole, ticlopidine, ciprofloxacin, cimetidine, carbamazepine,
Danish: Lægemidler, der hæmmer CYP2C19, inkluderer omeprazol og esomeprazol, fluvoxamin, fluoxetin, moclobemid, voriconazol, fluconazol, ticlopidin, ciprofloxacin, cimetidin, carbamazepin, oxcarbazepin og
English: Data from the CAPRIE study indicate that phenytoin and tolbutamide can be safely co-administered with clopidogrel.
Danish: Data fra CAPRIE-undersøgelsen indikerer, at phenytoin og tolbotamid uden risiko kan administreres samtidig med clopidogrel.
English: See leaflet for further information.
Danish: Læs indlægssedlen for information.
English: Clopidogrel BMS is supplied in cardboard cartons containing 7, 14, 28, 30, 84, 90 and 100 tablets in PVC/PVDC/Aluminium blisters or in all aluminium blisters, or 50x1 tablets in PVC/PVDC/Aluminium blisters or in all aluminium perforated unit-dose blisters.
Danish: Clopidogrel BMS udleveres i pakninger indeholdende tabletter (7, 14, 28, 30, 50, 84, 90 eller 100) i blisterpakninger af PVC/PVDC/aluminium eller aluminium, eller 50x1 tabletter i perforerede en-dosis PVC/PVDC/aluminum blister eller ren aluminium blister.
English: The population included 27.8% women, 58.4% patients ≥ 60 years (26% ≥ 70 years) and 54.5% patients who received fibrinolytics.
Danish: Populationen inkluderede 27,8 % kvinder, 58,4 % patienter ≥ 60 år (26 % ≥ 70 år) og
English: In CURE, the major bleeding event rate for clopidogrel+ASA was dose-dependent on ASA (<100mg: 2.6%; 100-200mg: 3.5%; >200mg: 4.9%) as was the major bleeding event rate for placebo+ASA (<100mg: 2.0%; 100-200mg: 2.3%; >200mg: 4.0%).
Danish: I CURE var forekomsten af større blødninger med clopidogrel+ASA dosisafhængig for ASA (<100 mg 2,6 %; 100-200 mg: 3,5 %; >200mg: 4,9 %), ligeledes var forekomsten af større blødninger for placebo+ASA (<100 mg: 2,0 %; 100-200 mg: 2,3 %; >200 mg: 4,0 %).
English: Always take Clopidogrel BMS exactly as your doctor has told you.
Danish: Tag altid Clopidogrel BMS nøjagtigt efter lægens anvisninger.
English: A total of 99.7% of patients received fibrinolytics (fibrin specific: 68.7%, non-fibrin specific: 31.1%), 89.5% heparin, 78.7% beta blockers, 54.7% ACE inhibitors and 63% statins.
Danish: En total på 99,7 % af patienterne fik fibrinolytika (fibrin specifik: 68,7 %, non-fibrin specifik: 31,1%), 89,5 % fik heparin, 78,7 % betablokkere, 54,7 % ACE-hæmmere og 63 % statiner.
English: PVC/PVDC/Aluminium blisters or all aluminium blisters in cardboard cartons containing 7, 14, 28, 30, 84, 90 and 100 film-coated tablets.
Danish: Blisterkort af PVC/PVDC/aluminium eller aluminium i kartonæsker der indeholder 7, 14, 28, 30, 50, 84, 90
English: Excipients: each tablet contains 12 mg lactose and 13.2 mg hydrogenated castor oil.
Danish: Hjælpestoffer: Hver tablet indeholder 12 mg lactose og 13,2 mg ricinusolie, hydrogeneret.
English: If Clopidogrel BMS is supplied in PVC/PVDC/aluminium blisters, store below 30°C.
Danish: Hvis Clopidogrel BMS er pakket i blisterkort af PVC/PVDC/aluminium, skal det opbevares under 30ºC.
English: However, if you are concerned by your bleeding, you should contact your doctor straightaway (see section 2 ‘Take special care with
Danish: Hvis De er bekymret over Deres blødning, skal De omgående kontakte Deres læge (se afsnit 2 'Vær ekstra forsigtig med at tage
English: Furthermore, the pharmacodynamic activity of clopidogrel was not significantly influenced by the co-administration of phenobarbital, cimetidine, or oestrogen.
Danish: Herudover blev clopidogrels farmakodynamiske aktivitet ikke påvirket signifikant af samtidig administration af phenobarbital, cimetidin eller østrogen.
English: Clopidogrel BMS belongs to a group of medicines called antiplatelet medicinal products.
Danish: Clopidogrel BMS tilhører en gruppe medicin, der kaldes blodfortyndende medicin.